2. Signaling Pathways
  3. Others
  4. MOFs

MOFs

Metal-Organic Frameworks

MOFs (Metal-Organic Frameworks) have significant applications in biomedicine, such as serving as drug carriers for targeted delivery and controlled release to enhance therapeutic efficacy and reduce side effects. They are also used in bioimaging, disease diagnosis, and catalytic therapies (e.g., for cancer treatment).

MOFs Related Products (3078):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W456474
    4,4'-Bis((1H-1,2,4-triazol-1-yl)methyl)-1,1'-biphenyl
    4,4'-Bis((1H-1,2,4-triazol-1-yl)methyl)-1,1'-biphenyl (4,4′-Bis((1H-1,2,4-triazol-1-yl)methyl)biphenyl) is a metal-organic framework (MOF).
    4,4'-Bis((1H-1,2,4-triazol-1-yl)methyl)-1,1'-biphenyl
  • HY-W074655
    4,4′,4′′-(1,3,5-Benzenetriyl)tris[1H-1,2,3-triazole-1-acetic acid]
    4,4′,4′′-(1,3,5-Benzenetriyl)tris[1H-1,2,3-triazole-1-acetic acid] (2-[4-[3,5-Bis[1-(carboxymethyl)triazol-4-yl]phenyl]triazol-1-yl]acetic acid) is a metal-organic framework (MOF).
    4,4′,4′′-(1,3,5-Benzenetriyl)tris[1H-1,2,3-triazole-1-acetic acid]
  • HY-W112903
    4,4′-(1,2-Diazenediyl)bis[2-methylbenzoic acid]
    4,4′-(1,2-Diazenediyl)bis[2-methylbenzoic acid] is a metal-organic framework (MOF).
    4,4′-(1,2-Diazenediyl)bis[2-methylbenzoic acid]
  • HY-W856080
    2,6-Di(4H-1,2,4-triazol-4-yl)-3a,4,4a,7a,8,8a-hexahydro-4,8-ethenopyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone
    2,6-Di(4H-1,2,4-triazol-4-yl)-3a,4,4a,7a,8,8a-hexahydro-4,8-ethenopyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone is a metal-organic framework (MOF).
    2,6-Di(4H-1,2,4-triazol-4-yl)-3a,4,4a,7a,8,8a-hexahydro-4,8-ethenopyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone
  • HY-W456312
    (1R,2R)-rel-N1,N2-Dimethyl-N1,N2-bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine
    (1R,2R)-rel-N1,N2-Dimethyl-N1,N2-bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine is a metal-organic framework (MOF).
    (1R,2R)-rel-N1,N2-Dimethyl-N1,N2-bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine
  • HY-W543329
    2-Hydroxy-4-(1,2,2-triphenylethenyl)-benzaldehyde
    2-Hydroxy-4-(1,2,2-triphenylethenyl)-benzaldehyde is a metal-organic framework (MOF).
    2-Hydroxy-4-(1,2,2-triphenylethenyl)-benzaldehyde
  • HY-W543344
    Diaqua[μ-[2,5-di(hydroxy-κO)-1,4-benzenedicarboxylato(4-)-κO1:κO4]]dimanganese
    Diaqua[μ-[2,5-di(hydroxy-κO)-1,4-benzenedicarboxylato(4-)-κO1:κO4]]dimanganese is a metal-organic framework (MOF).
    Diaqua[μ-[2,5-di(hydroxy-κO)-1,4-benzenedicarboxylato(4-)-κO1:κO4]]dimanganese
  • HY-W131246
    trans-Butane-1,2,3,4-tetracarboxylic acid
    trans-Butane-1,2,3,4-tetracarboxylic acid ((2R,3S)-1,2,3,4-Butanetetracarboxylic acid) is a metal-organic framework (MOF).
    trans-Butane-1,2,3,4-tetracarboxylic acid
  • HY-W354203
    N'-Isonicotinoylisonicotinohydrazide
    N'-Isonicotinoylisonicotinohydrazide (Compound 7, 1,2-Diisonicotinoylhydrazine) is a competitive inhibitor (IC50=5-30 μM) of bacterial heme oxygenase (HO). N'-Isonicotinoylisonicotinohydrazide inhibits iron release and bacterial iron acquisition. N'-Isonicotinoylisonicotinohydrazide exhibits selective activity against HO enzymes from Pseudomonas aeruginosa and Neisseria meningitidis. N'-Isonicotinoylisonicotinohydrazide is promising for research of multidrug-resistant Gram-negative bacterial infections.
    N'-Isonicotinoylisonicotinohydrazide
  • HY-W543650
    1,1''-Diallyl-6'-(1-allylpyridin-1-ium-4-yl)-[4,2':4',4''-terpyridine]-1,1''-diiumbromide
    1,1''-Diallyl-6'-(1-allylpyridin-1-ium-4-yl)-[4,2':4',4''-terpyridine]-1,1''-diiumbromide is a metal-organic framework (MOF).
    1,1''-Diallyl-6'-(1-allylpyridin-1-ium-4-yl)-[4,2':4',4''-terpyridine]-1,1''-diiumbromide
  • HY-W1049775
    UMCM-1
    UMCM-1 is a metal-organic framework (MOF).
    UMCM-1
  • HY-W112072
    Tris(4-(1H-1,2,4-triazol-1-yl)phenyl)amine
    Tris(4-(1H-1,2,4-triazol-1-yl)phenyl)amine is a metal-organic framework (MOF).
    Tris(4-(1H-1,2,4-triazol-1-yl)phenyl)amine
  • HY-W104812
    4,4'-(1,3,4-Oxadiazole-2,5-diyl)diphenol
    4,4'-(1,3,4-Oxadiazole-2,5-diyl)diphenol (2,5-Bis(4-hydroxyphenyl)-1,3,4-oxadiazole) is a metal-organic framework (MOF).
    4,4'-(1,3,4-Oxadiazole-2,5-diyl)diphenol
  • HY-W586906
    2',5'-Difluoro-[1,1':4',1''-terphenyl]-2,2'',5,5''-tetracarboxylic acid
    2',5'-Difluoro-[1,1':4',1''-terphenyl]-2,2'',5,5''-tetracarboxylic acid is a metal-organic framework (MOF).
    2',5'-Difluoro-[1,1':4',1''-terphenyl]-2,2'',5,5''-tetracarboxylic acid
  • HY-W456527
    2,2'-((4-Carboxy-1,2-phenylene)bis(oxy))diacetic acid
    2,2'-((4-Carboxy-1,2-phenylene)bis(oxy))diacetic acid is a metal-organic framework (MOF).
    2,2'-((4-Carboxy-1,2-phenylene)bis(oxy))diacetic acid
  • HY-W112976
    6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoicacid)
    6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoicacid) is a metal-organic framework (MOF).
    6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoicacid)
  • HY-W456332
    5'-(4-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid
    5'-(4-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid is a metal-organic framework (MOF).
    5'-(4-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid
  • HY-W1049820
    4,4',4'',4'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-nitrobenzoic acid)
    4,4',4'',4'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-nitrobenzoic acid) is a metal-organic framework (MOF).
    4,4',4'',4'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-nitrobenzoic acid)
  • HY-W075303
    4,4'-((2,2-Bis((pyridin-4-yloxy)methyl)propane-1,3-diyl)bis(oxy))dipyridine
    4,4'-((2,2-Bis((pyridin-4-yloxy)methyl)propane-1,3-diyl)bis(oxy))dipyridine (4,4'-[[2,2-Bis[(4-pyridinyloxy)methyl]-1,3-propanediyl]bis(oxy)]bis-pyridine) is a metal-organic framework (MOF).
    4,4'-((2,2-Bis((pyridin-4-yloxy)methyl)propane-1,3-diyl)bis(oxy))dipyridine
  • HY-W1049917
    Phenanthrene-2,7-dicarboxylic acid
    Phenanthrene-2,7-dicarboxylic acid is a metal-organic framework (MOF).
    Phenanthrene-2,7-dicarboxylic acid